Your browser doesn't support javascript.
loading
Improving Pneumococcal Vaccination Rates in High-risk Children in Specialty Clinics.
Harris, Julia G; Harris, Luke A; Olarte, Liset; Elson, E Claire; Moran, Rachel; Blowey, Douglas L; El Feghaly, Rana E.
Afiliación
  • Harris JG; Children's Mercy Kansas City, Kansas City, Missouri.
  • Harris LA; Schools of Medicine.
  • Olarte L; Children's Mercy Kansas City, Kansas City, Missouri.
  • Elson EC; Children's Mercy Integrated Care Solutions, Kansas City, Missouri.
  • Moran R; Children's Mercy Kansas City, Kansas City, Missouri.
  • Blowey DL; Schools of Medicine.
  • El Feghaly RE; Children's Mercy Kansas City, Kansas City, Missouri.
Pediatrics ; 149(4)2022 04 01.
Article en En | MEDLINE | ID: mdl-35233616
BACKGROUND AND OBJECTIVES: Pediatric patients with immunocompromising or certain chronic medical conditions have an increased risk of acquiring invasive pneumococcal disease (IPD). The 23-valent pneumococcal polysaccharide vaccine (PPSV23) is recommended for patients ≥2 years at high risk for IPDs. The aim of this project was to improve PPSV23 vaccination rates for children at high risk for IPD who were seen in 3 specialty clinics from ∼20% to 50% over a 12-month period. METHODS: The project team included quality improvement champions from the divisions of rheumatology, infectious diseases, and pulmonology in addition to leaders from our population health management subsidiary. Several initiatives were implemented, starting with review of patient inclusion criteria per the vaccination recommendations, that led to the design and deployment of an automated weekly previsit planning report. Additionally, we implemented a process to stock pneumococcal vaccines and shared best practices among the divisions. We monitored improvement through times series and run charts of PPSV23 vaccination rates. RESULTS: The initial PPSV23 vaccination rate for applicable high-risk patients was ∼20%. There was an increase in vaccination rate to ∼60%. All 3 divisions showed improvements in their individual PPSV23 vaccination rates. CONCLUSIONS: Using quality improvement methodology, we increased PPSV23 vaccination rates in 3 pediatric specialty clinics, and this improvement was sustained. We will continue to identify best practices and actively recruit additional divisions because we have the opportunity to reach >9000 high-risk patients.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Medicina Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatrics Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Infecciones Neumocócicas / Medicina Tipo de estudio: Etiology_studies / Guideline / Prognostic_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Pediatrics Año: 2022 Tipo del documento: Article Pais de publicación: Estados Unidos